KZR

Kezar Life Sciences (KZR)

About Kezar Life Sciences (KZR)

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.

Details

Daily high

$6.62

Daily low

$6.38

Price at open

$6.49

52 Week High

$7.45

52 Week Low

$3.53

Market cap

47.1M

Dividend yield

0.00%

Volume

19,733

Avg. volume

27,891

P/E ratio

-.76

Kezar Life Sciences News